NCT02420470 The Early Warning System for the Diabetic Encephalopathy
| NCT ID | NCT02420470 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tang-Du Hospital |
| Condition | Diabetes Mellitus Type 2 |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2015-04 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2015-04 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.
Eligibility Criteria
Inclusion Criteria: * without dementia * Inform Consent Form * Education time more than 6 years * blood glucose matches the group standard Exclusion Criteria: * Pregnant woman * suffer from serious brain disease * Magnetic resonance contraindications * lack of compliance * image quality is too poor to deal with
Contact & Investigator
Guangbin Cui, professor
✉ cgbtd@126.comGuangbin Cui, professor
STUDY CHAIR
Tang-Du Hospital
Frequently Asked Questions
Who can join the NCT02420470 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Diabetes Mellitus Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02420470 currently recruiting?
Yes, NCT02420470 is actively recruiting participants. Contact the research team at cgbtd@126.com for enrollment information.
Where is the NCT02420470 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT02420470 clinical trial?
NCT02420470 is sponsored by Tang-Du Hospital. The principal investigator is Guangbin Cui, professor at Tang-Du Hospital. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.